Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?
GLP-1/GIP receptor agonists, including semaglutide (Ozempic) and the investigational retatrutide, represent a seismic shift in cardiometabolic and comorbidity treatment. Over the past decade, the emerging drug class has been robustly …